Viewing Study NCT02794792


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-03 @ 6:39 AM
Study NCT ID: NCT02794792
Status: COMPLETED
Last Update Posted: 2024-11-12
First Post: 2016-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Sponsor: Astellas Pharma Europe B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus View
None ASP1941 View
None Ipragliflozin View